CM Management, LLC
- SEC CIK
- 0001841857
- Latest filing
- Aug 13, 2026
GANX holding history
Gain Therapeutics, Inc. in every 13F filed by CM Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GANX overviewAll 13F holders of GANXFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −90,000−100.0% | Sold out | Holders |
| Q2 2024 | 90,000 | $115.2K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 90,000 | $339.3K | 0.3% | 00.0% | Unchanged | Holders |
| Q4 2023 | 90,000 | $293.9K | 0.2% | 00.0% | Unchanged | Holders |
| Q3 2023 | 90,000 | $295.2K | 0.3% | 00.0% | Unchanged | Holders |
| Q2 2023 | 90,000 | $403.0K | 0.4% | 00.0% | Unchanged | Holders |
| Q1 2023 | 90,000 | $434.0K | 0.5% | −20,000−18.2% | Reduced | Holders |
| Q4 2022 | 110,000 | $344.0K | 0.4% | −15,000−12.0% | Reduced | Holders |
| Q3 2022 | 125,000 | $408.0K | 0.5% | 00.0% | Unchanged | Holders |
| Q2 2022 | 125,000 | $450.0K | 0.5% | 00.0% | Unchanged | Holders |
| Q1 2022 | 125,000 | $511.0K | 0.4% | +35,000+38.9% | Added | Holders |
| Q4 2021 | 90,000 | $489.0K | 0.4% | +25,673+39.9% | Added | Holders |
| Q3 2021 | 64,327 | $479.0K | 0.4% | +54,327+543.3% | Added | Holders |
| Q2 2021 | 10,000 | $100.0K | 0.1% | +10,000 | New | Holders |